Research Article
Colistin Resistance among Enterobacteriaceae Isolated from Clinical Samples in Gaza Strip
Table 2
Distribution of the isolates according to clinical sample type.
| Isolate | Sample type | Total | Urine | Pus | Sputum | H.V.S | CSF | Blood |
| E. coli | 38 | 11 | 1 | 1 | 0 | 0 | 51 | 74.5% | 21.6% | 2.0% | 2.0% | 0.0% | 0.0% | 100.0% |
| Enterobacter spp. | 1 | 2 | 1 | 0 | 0 | 0 | 4 | 25.0% | 50.0% | 25.0% | 0.0% | 0.0% | 0.0% | 100.0% |
| Proteus group | 7 | 9 | 1 | 0 | 0 | 2 | 19 | 36.8% | 47.4% | 5.3% | 0.0% | 0.0% | 10.5% | 100.0% |
| Serratia spp. | 0 | 5 | 2 | 0 | 0 | 0 | 7 | 0.0% | 71.4% | 28.6% | 0.0% | 0.0% | 0.0% | 100.0% |
| Klebsiella spp. | 12 | 4 | 2 | 0 | 1 | 0 | 19 | 63.2% | 21.1% | 10.5% | 0.0% | 5.3% | 0.0% | 100.0% |
| Total | 58 | 31 | 7 | 1 | 1 | 2 | 100 | 58.0% | 31.0% | 7.0% | 1.0% | 1.0% | 2.0% | 100.0% |
|
|
|